Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods

Biomaterials

Volumn 35, Issue 29, 2014, Pages 8374-8384

  Wang, Dangge ^a   Xu, Zhiai ^b   Yu, Haijun ^a   Chen, Xianzhi ^a   Feng, Bing ^a   Cui, Zhirui ^a   Lin, Bin ^b   Yin, Qi ^a   Zhang, Zhiwen ^a   Chen, Chunying ^c   Wang, Jun ^d   Zhang, Wen ^b   Li, Yaping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Chemotherapy; Doxorubicin; Gold nanorods; Metastatic breast cancer; Photothermal ablation

Indexed keywords

ABLATION; BLOOD VESSELS; CHEMOTHERAPY; DISEASES; GOLD; INFRARED DEVICES; NANOPARTICLES; NANORODS; PATHOLOGY; PLASMONS; TUMORS;

BREAST CANCER; BREAST CANCER CELLS; DOXORUBICIN; GOLD NANOROD; IMMUNOHISTOCHEMISTRY; NEAR INFRARED LIGHT; PHOTOTHERMAL ABLATION; TEMPERATURE ELEVATION;

NANORIBBONS;

DNA; DOXORUBICIN; GOLD NANOPARTICLE; NANOROD; ANTINEOPLASTIC ANTIBIOTIC; DNA ADDUCT; DOXORUBICIN-DNA; GOLD; NANOTUBE;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DNA HELIX; DRUG DISTRIBUTION; DRUG RELEASE; DRUG UPTAKE; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG METASTASIS; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PARTICLE SIZE; PHOTOCYTOTOXICITY; PHOTOTHERMAL ABLATION; PHOTOTOXICITY; PRIORITY JOURNAL; STATIC ELECTRICITY; SURFACE CHARGE; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; BREAST; BREAST NEOPLASMS; CHEMISTRY; DNA ADDUCT; DRUG EFFECTS; HUMAN; HYPERTHERMIC THERAPY; LUNG; LUNG NEOPLASMS; NUDE MOUSE; PATHOLOGY; PHOTOTHERAPY; SECONDARY; THERAPEUTIC USE; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA ADDUCTS; DOXORUBICIN; FEMALE; GOLD; HUMANS; HYPERTHERMIA, INDUCED; LUNG; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; NANOTUBES; PHOTOTHERAPY;

EID: 84904129067     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.094     Document Type: Article

References (42)

1. Mehlen P., Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006, 6:449-458.
2. Weigelt B., Peterse J.L., van 't Veer L.J. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005, 5:591-602.
3. Ma L., Reinhardt F., Pan E., Soutschek J., Bhat B., Marcusson E.G., et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010, 28:341-347.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
5. Folkman J., Bach M., Rowe J.W., Davidoff F., Lambert P., Hirsch C., et al. Tumor angiogenesis-therapeutic implications. NEngl J Med 1971, 285:1182-1186.
6. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
7. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
8. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7:192-198.
9. Maula S.M., Luukkaa M., Grenman R., Jackson D., Jalkanen S., Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003, 63:1920-1926.
10. van Deurzen C.H., de Boer M., Monninkhof E.M., Bult P., van der Wall E., Tjan-Heijnen V.C., et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. JNatl Cancer Inst 2008, 100:1574-1580.
11. Cserni G. Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after sentinel node procedure. JClin Pathol 2008, 61:1233-1235.
12. Mayer R.J. Two steps forward in the treatment of colorectal cancer. NEngl J Med 2004, 350:2406-2408.
13. Jain R.K. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001, 7:987-989.
14. Meng H., Xing G.M., Sun B.Y., Zhao F., Lei H., Li W., et al. Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano 2010, 4:2773-2783.
15. Mendel D.B., Schreck R.E., West D.C., Li G.M., Strawn L.M., Tanciongco S.S., et al. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Clin Cancer Res 2000, 6:4848-4858.
16. Bartczak D., Muskens O.L., Sanchez-Elsner T., Kanaras A.G., Millar T.M. Manipulation of invitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano 2013, 7:5628-5636.
17. Yang J.C., Haworth L., Sherry R.M., Hwu P., Schwartzentruber D.J., Topalian S.L., et al. Arandomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. NEngl J Med 2003, 349:427-434.
18. Tammela T., Saaristo A., Holopainen T., Yla-Herttuala S., Andersson L.C., Virolainen S., et al. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med 2011, 3:69ra11.
19. McAllaster J.D., Cohen M.S. Role of the lymphatics in cancer metastasis and chemotherapy applications. Adv Drug Deliv Rev 2011, 63:867-875.
20. Hirsch L.R., Stafford R.J., Bankson J.A., Sershen S.R., Rivera B., Price R.E., et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003, 100:13549-13554.
21. Welsher K., Sherlock S.P., Dai H. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window. Proc Natl Acad Sci U S A 2011, 108:8943-8948.
22. Guo C.S., Yin S., Yu H.J., Liu S.Q., Dong Q., Goto T., et al. Photothermal ablation cancer therapy using homogeneous CsxWO3 nanorods with broad near-infrared absorption. Nanoscale 2013, 5:6469-6478.
23. Yin Q., Shen J., Zhang Z., Yu H., Li Y. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv Drug Deliv Rev 2013, 65:1699-1715.
24. Park J.H., von Maltzahn G., Xu M.J., Fogal V., Kotamraju V.R., Ruoslahti E., et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A 2010, 107:981-986.
25. Grabinski C., Schaeublin N., Wijaya A., D'Couto H., Baxamusa S.H., Hamad-Schifferli K., et al. Effect of gold nanorod surface chemistry on cellular response. ACS Nano 2011, 5:2870-2879.
26. Lee S.M., Park H., Choi J.W., Park Y.N., Yun C.O., Yoo K.H. Multifunctional nanoparticles for targeted chemophotothermal treatment of cancer cells. Angew Chem Int Ed Engl 2011, 50:7581-7586.
27. Gao L., Fei J., Zhao J., Li H., Cui Y., Li J. Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy invitro. ACS Nano 2012, 6:8030-8040.
28. Wan D.H., Xia X.H., Wang Y.C., Xia Y.N. Robust synthesis of gold cubic nanoframes through a combination of galvanic replacement, gold deposition, and silver dealloying. Small 2013, 9:3111-3117.
29. Zhang Z.J., Wang L.M., Wang J., Jiang X.M., Li X.H., Hu Z.J., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
30. Shen S., Tang H., Zhang X., Ren J., Pang Z., Wang D., et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
31. Ren F., Bhana S., Norman D.D., Johnson J., Xu L., Baker D.L., et al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem 2013, 24:376-386.
32. Alexander C.M., Dabrowiak J.C., Maye M.M. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D. Bioconjug Chem 2012, 23:2061-2070.
33. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. JAm Chem Soc 2009, 131:14652-14653.
34. Chaires J.B., Herrera J.E., Waring M.J. Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments. Biochemistry 1990, 29:6145-6153.
35. Murphy C.J., San T.K., Gole A.M., Orendorff C.J., Gao J.X., Gou L., et al. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. JPhys Chem B 2005, 109:13857-13870.
36. Bagalkot V., Farokhzad O.C., Langer R., Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl 2006, 45:8149-8152.
37. Huschka R., Zuloaga J., Knight M.W., Brown L.V., Nordlander P., Halas N.J. Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods. JAm Chem Soc 2011, 133:12247-12255.
38. Betancourt T., Brown B., Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and invitro evaluation. Nanomedcine 2007, 2:219-232.
39. Yu H., Zou Y., Wang Y., Huang X., Huang G., Sumer B.D., et al. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano 2011, 5:9246-9255.
40. Fujiwara Y., Kikuchi H., Aizawa S., Furuta A., Hatanaka Y., Konya C., et al. Direct uptake and degradation of DNA by lysosomes. Autophagy 2013, 9:1167-1171.
41. Khlebtsov N., Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of invitro and invivo studies. Chem Soc Rev 2011, 40:1647-1671.
42. Huang X., Peng X., Wang Y., Shin D.M., El-Sayed M.A., Nie S. Areexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4:5887-5896.